Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2646-2023Class II

BD Pyxis MedBank MedPass Software, REF: 139088-01

CareFusion 303, Inc / initiated 2023-08-18 / Open, Classified / root cause: design

CareFusion 303, Inc. began a recall of BD Pyxis MedBank MedPass Software, REF: 139088-01 on . FDA classified it as Class II and gives the reason as "After dispensing a timed dose medication for a patient, the automated dispensing cabinet software may continue to show the already dispensed medication dose is still available for dispense, which could lead to duplicate...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as design.

Recall record

Recall number
Z-2646-2023
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
CareFusion 303, Inc
Product
BD Pyxis MedBank MedPass Software, REF: 139088-01
Product code
BRY Cabinet, Table And Tray, Anesthesia
Reason for recall
After dispensing a timed dose medication for a patient, the automated dispensing cabinet software may continue to show the already dispensed medication dose is still available for dispense, which could lead to duplicate medication administration.
Root cause tag
design
FDA root cause
Device Design
Action
On 8/18/23, correction notices were mailed to directors of Biomedical Engineering/Risk Management/Nursing/Pharmacy and distributors. They were asked to take the following actions: 1) Remind users that affected devices do not replace the electronic (or paper) patient record, specifically the medication order, which will remain accurate and serves as the source of truth for medication administration. Nursing best practice is to confirm the 5 rights of medication orders prior to administration. Some inpatient psychiatric units also utilize barcode medication administration (BCMA) which may detect duplicate administrations. If a duplicate medication is inadvertently administered, ensure the patient is appropriately monitored and follow organizational process for reporting of a medication error. 2. Please ensure this letter is forwarded to applicable facilities if devices have been transferred and that all appropriate personnel have been made aware of this issue. 3. Complete and return the response form. Adverse health consequences experienced with the use of this product should be reported to BD at 1-800-727-6102 or via bd.com/self-service The recall issue will be resolved in software v1.2, which will be provided to all customers approximately October 2023 via remote upgrade. On 8/26/24, correction-update notices were sent informing customers the field correction (software update to BD Pyxis MedBank MedPass software v1.2.1.17) was not effective. As a result, devices required an additional update to BD Pyxis MedBank MedPass software version v1.2.3.23.
Quantity in commerce
37
Distribution
US: FL, MI, KS
Product codes and lots
UDI-DI: 10885403513817, Software versions prior to but not including v1.2.3.23

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2646-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2646-2023Class IIOngoingVoluntary: Firm initiated